EUVIMEDEUVIMED entdecken
Crossref

Endothelial LRRC8A delays vascular ageing in natural and accelerated ageing mouse models

Jinlong Pang, Lei Pan, Wei Shen, Gangsi Yi, Xu Kong, Heqiang Zhang, Baolong Feng, Hu Sun, Liangcai Chen, Guiyang Li, Hui Zhuang, Jiajin Chen und 4 weitere

Cardiovascular Research · 18.12.2025 · 121 (16) · 2549-2564

DOI: 10.1093/cvr/cvaf212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 06.11.2025. Verfasst von Jinlong Pang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, Chi…. Hauptthemen laut MEDLINE: Cellular Senescence, Aging, Endothelial Cells, Membrane Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Fund of Fujian province, Xiamen Municipal Bureau of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Vascular ageing (VA), characterized by vascular endothelial dysfunction, is a major contributor to age-related chronic conditions. Leucine-rich repeat-containing protein 8A (LRRC8A) is vital in maintaining vascular endothelial function; however, the role of endothelial LRRC8A in VA is undefined. We aimed to investigate the role and mechanism of endothelial LRRC8A in VA. Methods and results We found that LRRC8A expression was clearly down-regulated in the aged murine aortas. Further integrated analysis of single-cell and bulk RNA-seq and experimental verification revealed that endothelial LRRC8A governed VA by counteracting cell cycle, cellular senescence, and oxidative stress. Additionally, endothelial LRRC8A deletion exacerbated the D-galactose (D-gal)-induced VA progression. Mechanistically, endothelial LRRC8A phosphorylated AMPK at T172 and subsequently facilitated SIRT1 nuclear translocation, ultimately counteracting the p53-dependent senescence pathway and activating the FOXO3-dependent antioxidant pathway. Therapeutically, pharmacological agonists of AMPK and SIRT1 effectively rescued endothelial cell senescence and VA in the context of endothelial LRRC8A deficiency. Additionally, endothelial-targeted adeno-associated virus (AAV)-LRRC8A gene therapy can effectively delay the progression of VA in naturally ageing mice.

Conclusion

Our findings provide the first evidence supporting endothelial LRRC8A as a novel modulator of the AMPK–SIRT1 axis and suggest that targeting LRRC8A represents a promising therapeutic strategy for VA and age-related chronic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceAgingEndothelial CellsMembrane ProteinsAortaAnimalsSirtuin 1Signal TransductionOxidative StressMice, Inbred C57BLMice, KnockoutAMP-Activated Protein KinasesDisease Models, AnimalForkhead Box Protein O3Cells, CulturedTumor Suppressor Protein p53Age FactorsMaleHumansPhosphorylation

Stichwörter der Autor:innen

Cellular senescenceEndothelial cellLRRC8AOxidative stressVascular ageing

Substanzen

Sirtuin 1Membrane ProteinsSirt1 protein, mouseAMP-Activated Protein KinasesForkhead Box Protein O3Tumor Suppressor Protein p53FoxO3 protein, mouseTrp53 protein, mouse

Autor:innen und Institutionen

  • Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  • Haicang Hospital, Xiamen Medical College, Xiamen, Fujian, China.
  • Department of Vascular Surgery, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  • Department of Cardiac Surgery, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  • Department of Cardiology, Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  • Xiamen Key Laboratory of Cardiovascular Disease, Xiamen, Fujian, China.

ORCID-Profile: Yan Wang, Yanhui Zhang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Fund of Fujian province
  • Xiamen Municipal Bureau of Science and Technology

Zitieren

APA

Pang, J., Pan, L., Shen, W., Yi, G., Kong, X., Zhang, H., Feng, B., Sun, H., Chen, L., Li, G., Zhuang, H., Chen, J., Lu, L., Wang, Y., Jie, L., & Zhang, Y. (2025). Endothelial LRRC8A delays vascular ageing in natural and accelerated ageing mouse models. Cardiovascular Research, 121(16), 2549-2564. https://doi.org/10.1093/cvr/cvaf212

Vancouver

Pang J, Pan L, Shen W, Yi G, Kong X, Zhang H, et al. Endothelial LRRC8A delays vascular ageing in natural and accelerated ageing mouse models. Cardiovascular Research. 2025;121(16):2549-2564. doi:10.1093/cvr/cvaf212

BibTeX
@article{Pang2025,
  author = {Pang, Jinlong and Pan, Lei and Shen, Wei and Yi, Gangsi and Kong, Xu and Zhang, Heqiang and Feng, Baolong and Sun, Hu and Chen, Liangcai and Li, Guiyang and Zhuang, Hui and Chen, Jiajin and Lu, Lin and Wang, Yan and Jie, Lingjun and Zhang, Yanhui},
  title = {Endothelial LRRC8A delays vascular ageing in natural and accelerated ageing mouse models},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {16},
  pages = {2549--2564},
  doi = {10.1093/cvr/cvaf212}
}
Kostenlos starten →